共 212 条
[1]
Bonkat G(2013)Increasing prevalence of ciprofloxacin resistance in extended-spectrum-β-lactamase-producing World J Urol 31 1427-1432
[2]
Müller G(2012) urinary isolates Int J Clin Pract 66 891-896
[3]
Braissant O(2015)Epidemiology, risk factors and comorbidity for urinary tract infections caused by extended-spectrum beta-lactamase (ESBL)-producing enterobacteria J Urol 193 552-556
[4]
Frei R(2006)Fluoroquinolone resistance in the rectal carriage of men in an active surveillance cohort: longitudinal analysis Urology 68 1169-1174
[5]
Tschudin-Suter S(2013)Epidemiology of urinary tract infections caused by extended-spectrum beta-lactamase-producing Antimicrob Agents Chemother 57 3092-3099
[6]
Rieken M(2011)Appropriateness of empirical treatment and outcome in bacteremia caused by extended-spectrum-β-lactamase-producing bacteria Clin Infect Dis 52 e103-e120
[7]
Wyler S(2013)International clinical practice guidelines for the treatment of acute uncomplicated cystitis and pyelonephritis in women: a 2010 update by the Infectious Diseases Society of America and the European Society for Microbiology and Infectious Diseases Int J Antimicrob Agents 41 224-228
[8]
Gasser TC(2012)Monitoring the global in vitro activity of ertapenem against Diagn Microbiol Infect Dis 74 62-67
[9]
Bachmann A(2008) from intra-abdominal infections: SMART 2002–2010 Clin Infect Dis 47 S3-S13
[10]
Widmer AF(2014)Antimicrobial susceptibility of Enterobacteriaceae, including molecular characterization of extended-spectrum beta-lactamase-producing species, in urinary tract isolates from hospitalized patients in North America and Europe: results from the SMART study 2009–2010 Arch Gerontol Geriatr 58 105-109